$NEO
NEOGENOMICS INC

2014 Q4 Form 10-K Financial Statement

#000119312515075318 Filed on March 03, 2015

View on sec.gov

Income Statement

Concept 2014 Q4 2014 2013 Q4
Revenue $25.00M $87.07M $18.32M
YoY Change 36.44% 31.0% 23.02%
Cost Of Revenue $13.50M $46.36M $9.200M
YoY Change 46.74% 33.47% 8.24%
Gross Profit $11.47M $40.71M $9.163M
YoY Change 25.2% 28.29% 42.44%
Gross Profit Margin 45.89% 46.76% 50.01%
Selling, General & Admin $9.700M $35.81M $7.300M
YoY Change 32.88% 37.07% 25.86%
% of Gross Profit 84.55% 87.95% 79.67%
Research & Development $400.0K $2.689M $600.0K
YoY Change -33.33% 10.2% 50.0%
% of Gross Profit 3.49% 6.6% 6.55%
Depreciation & Amortization $1.510M $5.345M $1.120M
YoY Change 34.82% 27.6% -1.75%
% of Gross Profit 13.16% 13.13% 12.22%
Operating Expenses $10.20M $38.50M $7.900M
YoY Change 29.11% 34.78% 27.42%
Operating Profit $1.272M $2.218M $1.263M
YoY Change 0.71% -30.12% 442.06%
Interest Expense -$200.0K $985.0K -$200.0K
YoY Change 0.0% -0.4% -33.33%
% of Operating Profit -15.72% 44.41% -15.84%
Other Income/Expense, Net -$929.0K
YoY Change -6.07%
Pretax Income $1.100M $1.289M $1.000M
YoY Change 10.0% -41.01% -1100.0%
Income Tax $100.0K $157.0K $100.0K
% Of Pretax Income 9.09% 12.18% 10.0%
Net Earnings $1.047M $1.132M $857.0K
YoY Change 22.17% -44.32% -851.75%
Net Earnings / Revenue 4.19% 1.3% 4.68%
Basic Earnings Per Share $0.02 $0.02 $0.02
Diluted Earnings Per Share $0.02 $0.02 $0.02
COMMON SHARES
Basic Shares Outstanding 60.04M 53.48M 49.02M shares
Diluted Shares Outstanding 62.73M 56.02M 53.64M shares

Balance Sheet

Concept 2014 Q4 2014 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.70M $33.70M $4.800M
YoY Change 602.08% 602.08% 152.63%
Cash & Equivalents $33.69M $33.70M $4.834M
Short-Term Investments
Other Short-Term Assets $2.000M $2.000M $1.700M
YoY Change 17.65% 17.65% 112.5%
Inventory $2.616M $2.600M $2.301M
Prepaid Expenses $1.115M
Receivables $20.48M $20.50M $18.65M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $58.74M $58.70M $27.49M
YoY Change 113.68% 113.45% 47.95%
LONG-TERM ASSETS
Property, Plant & Equipment $15.08M $15.10M $9.694M
YoY Change 55.58% 55.67% 12.63%
Goodwill $2.929M
YoY Change
Intangibles $2.577M
YoY Change -7.96%
Long-Term Investments
YoY Change
Other Assets $141.0K $100.0K $154.0K
YoY Change -8.44% -50.0% 85.54%
Total Long-Term Assets $22.36M $22.40M $12.43M
YoY Change 79.99% 80.65% 8.14%
TOTAL ASSETS
Total Short-Term Assets $58.74M $58.70M $27.49M
Total Long-Term Assets $22.36M $22.40M $12.43M
Total Assets $81.11M $81.10M $39.92M
YoY Change 103.19% 103.26% 32.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.294M $6.300M $4.177M
YoY Change 50.68% 50.0% 15.67%
Accrued Expenses $1.208M $5.100M $741.0K
YoY Change 63.02% 64.52% 10.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $4.300M
YoY Change -100.0% -100.0% -49.41%
Long-Term Debt Due $3.200M $3.200M $2.800M
YoY Change 14.29% 14.29% 27.27%
Total Short-Term Liabilities $14.62M $14.60M $14.32M
YoY Change 2.09% 2.1% -19.34%
LONG-TERM LIABILITIES
Long-Term Debt $5.300M $5.300M $3.300M
YoY Change 60.61% 60.61% 6.45%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $6.078M $5.300M $3.882M
YoY Change 56.57% 60.61% 25.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.62M $14.60M $14.32M
Total Long-Term Liabilities $6.078M $5.300M $3.882M
Total Liabilities $20.70M $20.70M $18.21M
YoY Change 13.71% 13.74% -12.71%
SHAREHOLDERS EQUITY
Retained Earnings -$19.41M -$20.54M
YoY Change -5.51% -9.01%
Common Stock $79.81M $42.25M
YoY Change 88.91% 32.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $60.41M $60.40M $21.71M
YoY Change
Total Liabilities & Shareholders Equity $81.11M $81.10M $39.92M
YoY Change 103.19% 103.26% 32.74%

Cashflow Statement

Concept 2014 Q4 2014 2013 Q4
OPERATING ACTIVITIES
Net Income $1.047M $1.132M $857.0K
YoY Change 22.17% -44.32% -851.75%
Depreciation, Depletion And Amortization $1.510M $5.345M $1.120M
YoY Change 34.82% 27.6% -1.75%
Cash From Operating Activities $990.0K $9.450M -$500.0K
YoY Change -298.0% 324.34%
INVESTING ACTIVITIES
Capital Expenditures -$1.050M $3.772M -$520.0K
YoY Change 101.92% 87.57% 48.57%
Acquisitions $5.830M
YoY Change
Other Investing Activities $0.00 -$5.830M
YoY Change
Cash From Investing Activities -$1.050M -$9.600M -$520.0K
YoY Change 101.92% 377.37% 48.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $34.25M
YoY Change 279.84%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -610.0K 29.01M 930.0K
YoY Change -165.59% 954.91% 416.67%
NET CHANGE
Cash From Operating Activities 990.0K 9.450M -500.0K
Cash From Investing Activities -1.050M -9.600M -520.0K
Cash From Financing Activities -610.0K 29.01M 930.0K
Net Change In Cash -670.0K 28.86M -90.00K
YoY Change 644.44% 873.03% -47.06%
FREE CASH FLOW
Cash From Operating Activities $990.0K $9.450M -$500.0K
Capital Expenditures -$1.050M $3.772M -$520.0K
Free Cash Flow $2.040M $5.678M $20.00K
YoY Change 10100.0% 2528.7% -94.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Share Price
SharePrice
3.00
CY2014Q3 us-gaap Share Price
SharePrice
4.60
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.87
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4779170 shares
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2150000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
5897000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2628000
CY2014Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
37000
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
60255943 shares
CY2007Q2 neo Warrants Issued
WarrantsIssued
348417 shares
CY2014Q2 dei Entity Public Float
EntityPublicFloat
138900000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.02
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.73
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5777212 shares
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3002000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
9216000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2012Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1868000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49118373 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49118373 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.22
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.19
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1520625 shares
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.02
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5725298 shares
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14478000
CY2013Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4282000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14323000
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
3294000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4540000
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3882000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
49000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
405000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.27
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4177000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20538000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
588000
CY2013Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
5038000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
42200000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
741000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
21711000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39916000
CY2013Q4 us-gaap Liabilities
Liabilities
18205000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2337000
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2786000
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4834000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
588000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9694000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1115000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2577000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24172000
CY2013Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
10507000
CY2013Q4 us-gaap Assets
Assets
39916000
CY2013Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
5469000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2013Q4 us-gaap Inventory Net
InventoryNet
2301000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18653000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
154000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
27491000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2982000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60242818 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60242818 shares
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
1.27
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.04
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2379378 shares
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
2.04
CY2014Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2379378 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.50
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.48
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
7000000 shares
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1632718 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
650000 shares
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.35
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4012096 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
388000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4012096 shares
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
8481000
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
1601000
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
3191000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19822000
CY2014Q4 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
191000
CY2014Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
301000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14623000
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
5257000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4180000
CY2014Q4 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
301000
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
6078000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
60000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6294000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19406000
CY2014Q4 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
293000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
821000
CY2014Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
4959000
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
3784000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
79751000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1208000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
60405000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2693000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
483000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81106000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
700000
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
9123000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
928000
CY2014Q4 us-gaap Liabilities
Liabilities
20701000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3897000
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3224000
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2014Q4 us-gaap Purchase Obligation
PurchaseObligation
1387000
CY2014Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
301000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1282000
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
518000
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
642000
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
29000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2013Q1 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
10000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33689000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
821000
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1200000
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
371000
CY2014Q4 us-gaap Goodwill
Goodwill
2929000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15082000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1141000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
8800000
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4212000
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
371000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34904000
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6900000
CY2014Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
13000000
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2357000
CY2014Q4 us-gaap Assets
Assets
81106000
CY2014Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
8041000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
371000
CY2014Q4 us-gaap Inventory Net
InventoryNet
2616000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20475000
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
371000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
141000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
58742000
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
371000
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4912000
CY2014Q4 neo Royalty Payable As Percentage Of Sublicensing Revenue
RoyaltyPayableAsPercentageOfSublicensingRevenue
0.50 pure
CY2014Q4 neo Royalty Payable As Percentage Of Net Revenue
RoyaltyPayableAsPercentageOfNetRevenue
0.065 pure
CY2014Q4 neo Property Plant And Equipment Minimum Cost
PropertyPlantAndEquipmentMinimumCost
1000
CY2014Q4 neo Milestone Payment To Be Made Upon Incremental Revenue
MilestonePaymentToBeMadeUponIncrementalRevenue
500000
CY2014Q4 neo Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber
2379378 shares
CY2014Q4 neo Capital Leases Weighted Average Interest Rate
CapitalLeasesWeightedAverageInterestRate
0.0916 pure
CY2014Q4 neo Maximum Milestone Payment To Be Made
MaximumMilestonePaymentToBeMade
5000000
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2014Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
62500
CY2014Q3 neo Line Of Credit Facility Termination Fee
LineOfCreditFacilityTerminationFee
61000
CY2012Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.020 pure
CY2012Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2015-03-26
CY2012Q1 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
80000
CY2012Q1 neo Line Of Credit Facility Commitment Fee Percentage If Revolver Terminated Two Years Before Amendment Date
LineOfCreditFacilityCommitmentFeePercentageIfRevolverTerminatedTwoYearsBeforeAmendmentDate
0.015 pure
CY2012Q1 neo Line Of Credit Facility Commitment Fee Percentage If Revolver Terminated One Year Before Amendment Date
LineOfCreditFacilityCommitmentFeePercentageIfRevolverTerminatedOneYearBeforeAmendmentDate
0.025 pure
CY2012Q1 neo Minimum Termination Fee Grace Period
MinimumTerminationFeeGracePeriod
P5D
CY2012Q1 neo Line Of Credit Facility Commitment Fee Percentage If Revolver Terminated Two Years After Amendment Date
LineOfCreditFacilityCommitmentFeePercentageIfRevolverTerminatedTwoYearsAfterAmendmentDate
0.005 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
416000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007 pure
CY2013 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
76595 shares
CY2014Q4 neo Base Salary
BaseSalary
1717000
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4544 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0026 pure
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.47
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52775000 shares
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2013 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.04
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.66
CY2014Q2 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
5000
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.46 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.1445 pure
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
438998 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48263000 shares
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9968000
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
230000
CY2012Q2 neo Related Party Retainer Compensation
RelatedPartyRetainerCompensation
210000
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3322500 shares
CY2013Q1 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
800000
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9200000
CY2013Q1 neo Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
10000000
CY2014Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
8050000 shares
CY2014Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2700000
CY2014Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
34300000
CY2014Q3 neo Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
37000000
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.85
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0693 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0189 pure
CY2013 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4512000 shares
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2227000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
28916 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0177 pure
CY2013 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.04
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
349000
CY2013 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
173784000
CY2013 us-gaap Gross Profit
GrossProfit
31737000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
552000
CY2013 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
71000
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
442000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2185000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
3174000
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-989000
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
17000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
372000
CY2013 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
2606000
CY2013 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
66467000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
2033000
CY2013 us-gaap Interest Paid
InterestPaid
945000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7416000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2011000
CY2013 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
263000
CY2013 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
932000
CY2013 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
3377000
CY2013 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
666000
CY2013 us-gaap Operating Expenses
OperatingExpenses
28563000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2440000
CY2013 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8726000
CY2013 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
2900000
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
49000
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2797000
CY2013 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1259000
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
223000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2966000
CY2013 us-gaap Cost Of Services
CostOfServices
34730000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
152000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1072000
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
93000
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4189000
CY2013 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
372000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2750000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9018000
CY2013 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1037000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
59000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2011000
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
152000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17397000
CY2013 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
868000
CY2013 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
515000
CY2013 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-4177000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
666000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1200000
CY2013 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
275000
CY2013 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2013 neo Oncology Practice Combined Represented Revenue
OncologyPracticeCombinedRepresentedRevenue
0.158 pure
CY2013 neo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue
493000
CY2013 neo Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
107317000
CY2013 neo Stock Based Compensation Warrant Expense
StockBasedCompensationWarrantExpense
263000
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.02 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.85
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.76
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Entity Registrant Name
EntityRegistrantName
NEOGENOMICS INC
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Trading Symbol
TradingSymbol
NEO
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.50
CY2014 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y7M6D
CY2014 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1216 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0589 pure
CY2014 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y2M12D
CY2014 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2533000 shares
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
9450000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
86375 shares
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
82667 shares
CY2014 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
"The LIBOR shall be not less than 2.0%" and replacing it with "the LIBOR shall be not less than 1.0%"
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0337 pure
CY2014 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.02
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1596 pure
CY2014 us-gaap Operating Loss Carryforwards Expiration Date
OperatingLossCarryforwardsExpirationDate
2028-12-31
CY2014 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
760500 shares
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
565740 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
CY2014 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
90285 shares
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <u>Use of Estimates</u></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America. These principles require management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the consolidated financial statements. Actual results and outcomes may differ from management&#x2019;s estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these consolidated financial statements include, but are not limited to, those related to revenues, accounts receivable and related allowances, contingencies, useful lives and recovery of long-term assets and intangible assets, income taxes and valuation allowances, stock-based compensation and impairment analysis of goodwill. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected in the consolidated financial statements prospectively from the date of the change in estimate.</p> </div>
CY2014 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P1Y
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.95
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.39
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56016000 shares
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2014 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.2793 pure
CY2014 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.02
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.21
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001077183
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11999000
CY2014 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
3000000
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400 pure
CY2014 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
51000
CY2014 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
66000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.50 pure
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0400 pure
CY2014 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segments
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
5000000
CY2014 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
87069000
CY2014 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
25000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2770000
CY2014 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-41000
CY2014 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
5884000
CY2014 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
224460000
CY2014 us-gaap Gross Profit
GrossProfit
40714000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
641000
CY2014 us-gaap Operating Expenses
OperatingExpenses
38496000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2689000
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
174000
CY2014 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y3M18D
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2387327 shares
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53483000 shares
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37030000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
540000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
229000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1289000
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
353000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1807000
CY2014 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5830000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
2218000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-929000
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
177000
CY2014 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
3581000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3772000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
1132000
CY2014 us-gaap Interest Paid
InterestPaid
981000
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2437000
CY2014 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2797000
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
295000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
28855000
CY2014 us-gaap Cost Of Services
CostOfServices
46355000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
157000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1705000
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
113000
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5345000
CY2014 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
1807000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
29007000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
34254000
CY2014 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2776000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
44000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9602000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
157000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23808000
CY2014 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
2466000
CY2014 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2616000
CY2014 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-4282000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
641000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8882000
CY2014 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
358000
CY2014 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2014 neo Individual Clients Revenue
IndividualClientsRevenue
Less than 5%
CY2014 neo Milestone Payments
MilestonePayments
0
CY2014 neo Purchase Commitments Expiration Period
PurchaseCommitmentsExpirationPeriod
2019-10
CY2014 neo Oncology Practice Combined Represented Revenue
OncologyPracticeCombinedRepresentedRevenue
0.101 pure
CY2014 neo Area Of Office Space
AreaOfOfficeSpace
49000 sqft
CY2014 neo Exercise Of Warrants
ExerciseOfWarrants
456000
CY2014 neo Share Based Compensation Arrangement Amended Plan Expiration Date
ShareBasedCompensationArrangementAmendedPlanExpirationDate
2019-03-03
CY2014 neo Agreement Expiration Date
AgreementExpirationDate
2017-01-05
CY2014 neo Related Party Retainer Compensation
RelatedPartyRetainerCompensation
180000
CY2014 neo Amount Of Revenue Recognized For Milestone
AmountOfRevenueRecognizedForMilestone
2000000
CY2014 neo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue
1139000
CY2014 neo Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
137391000
CY2014 neo Largest Amount Of Tax Benefit
LargestAmountOfTaxBenefit
Greater than 50%
CY2014 neo Extended Duration To Commercialize Products
ExtendedDurationToCommercializeProducts
P2Y
CY2014 neo Share Based Compensation Arrangement By Share Based Payment Award Value Of Stock Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfStockOptionsGranted
48850
CY2014 neo Deemed Value Per Share Of Consideration Payable To Common Stockholders In Event Of Change In Control
DeemedValuePerShareOfConsiderationPayableToCommonStockholdersInEventOfChangeInControl
4.17
CY2014 neo Stock Based Compensation Warrant Expense
StockBasedCompensationWarrantExpense
51000
CY2014 neo Effective Income Tax Rate Reconciliation Nondeductible Tax Expense
EffectiveIncomeTaxRateReconciliationNondeductibleTaxExpense
0.0879 pure
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.02
CY2012 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3688000 shares
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-492000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
102749 shares
CY2012 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.00
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1298000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.006 pure
CY2012 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
56805 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.60
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48715000 shares
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2012 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.00
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.64
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.51 pure
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
197209 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45027000 shares
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
218000
CY2012 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
157591000
CY2012 us-gaap Gross Profit
GrossProfit
26836000
CY2012 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-46000
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
657000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65000
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
89000
CY2012 neo Exercise Of Warrants
ExerciseOfWarrants
262000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
198000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
1211000
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1146000
CY2012 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1037000
CY2012 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
2187000
CY2012 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
198000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2615000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
65000
CY2012 us-gaap Interest Paid
InterestPaid
1108000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9192000
CY2012 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
153000
CY2012 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
59867000
CY2012 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-96000
CY2012 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
2782000
CY2012 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
645000
CY2012 us-gaap Operating Expenses
OperatingExpenses
25625000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2281000
CY2012 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7501000
CY2012 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
3100000
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
38000
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3053000
CY2012 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2201000
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
182000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-760000
CY2012 us-gaap Cost Of Services
CostOfServices
33031000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2012 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
1945000
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1123000
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3636000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3384000
CY2012 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
38000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3652000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15843000
CY2012 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
1443000
CY2012 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
511000
CY2012 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
500000
CY2012 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4560000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
645000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
264000
CY2012 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
220000
CY2012 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2012 neo Oncology Practice Combined Represented Revenue
OncologyPracticeCombinedRepresentedRevenue
0.149 pure
CY2012 neo Stock Issued During Period Value Intangibles
StockIssuedDuringPeriodValueIntangibles
1945000
CY2012 neo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue
943000
CY2012 neo Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
97724000
CY2012 neo Albitar Warrant Period
AlbitarWarrantPeriod
P5Y
CY2012 neo Stock Based Compensation Warrant Expense
StockBasedCompensationWarrantExpense
153000

Files In Submission

Name View Source Status
0001193125-15-075318-index-headers.html Edgar Link pending
0001193125-15-075318-index.html Edgar Link pending
0001193125-15-075318.txt Edgar Link pending
0001193125-15-075318-xbrl.zip Edgar Link pending
d832983d10k.htm Edgar Link pending
d832983dex211.htm Edgar Link pending
d832983dex231.htm Edgar Link pending
d832983dex232.htm Edgar Link pending
d832983dex311.htm Edgar Link pending
d832983dex312.htm Edgar Link pending
d832983dex313.htm Edgar Link pending
d832983dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g832983g34a86.jpg Edgar Link pending
neo-20141231.xml Edgar Link completed
neo-20141231.xsd Edgar Link pending
neo-20141231_cal.xml Edgar Link unprocessable
neo-20141231_def.xml Edgar Link unprocessable
neo-20141231_lab.xml Edgar Link unprocessable
neo-20141231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending